| Thanks to SoCalBio Weekly Update Sponsor |
Coming in 2010 Benefiting When: June 28, 2010Time: 10:00am - 8:30pm Where: Old Ranch Country Club, Seal Beach, California |
Recommended Event
Export Assistance Training Program March 12, 2010 Irvine Chamber of Commerce More Information
|
Cut Cost of Doing Business Through the SoCalBio's Group Purchasing Program

SoCalBio members can buy pre-owned scientific research equipment from BioSurplus during its auction to be held on March 24. Click here to learn more
|
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| March 8, 2010  | |
Now Available
| Video Clips of the Feb 25 SoCalBio Networking Forum Focusing on the Biosciences in the Media
|
| RSVP Now for Upcoming SoCalBio Events | 
SoCalBio Networking Forum in Orange County Showcasing Non-Invasive Medical Technologies More InfoDate: March 25, 2010 Time: 7:00 am - 9:30 am Location: UCI University Club RSVP: https://www.123signup.com/register?id=jyrvf ************************************************
SoCalBio Executive Roundtable Discussion
Regenerative Medicine Luncheon and Discussion (Open only to executives and managers in regenerative medicine companies)
Date: April 6, 2010 Time 11:00 am - 2:00 pm Location: Offices of Reed Smith in Downtown Los Angeles By Invitation Only (for more info, contact SoCalBio at scbc@socalbio.org or call 213-236-4890)
************************************************* SoCalBio HR Symposium Best Practices in Designing Wellness Programs Join us to learn how to craft wellness programs to improve employee health, reduce medical claims, and guarantee a return on investment (Open only to HR professionals in medical device, IVD, biotech and generic pharma firms)
Date: April 15, 2010 Time: 9:00 am - 1:30 pm Location: One Lambda Corp. (Canoga Park) By Invitation Only (for more info, contact SoCalBio at scbc@socalbio.org or call 213-236-4890)
Join the SoCalBio HR Network on LinkedIn
************************************************* SoCalBio Regulatory Best Practice Workshop The Shifting Paradigm in FDA Process Validation
This SoCalBio workshop focuses on the FDA's guidelines regarding Process Validation. It is designed for device and pharma regulatory affairs professionals to learn what is required to approach process validation from a life cycle perspective and incorporates modern risk management and quality systems tools and concepts. |
 |  |
Expensive Drugs
| The List of Most Expensive Drugs
Forbes magazine survey finds top nine drugs, all costing more than $200,000 annually. All of the drugs qualify as "orphan" and most are "ultra-orphan" .... Click here to see the list |
Trends
| Personalized Medicine Could Shake Up Pharma
In the game of pharma, companies may have to give up on the home run known as the blockbuster drug-products like Lipitor and Avastin that were marketed to large swaths of the population and generated billions in sales-and hope that well-timed singles and doubles can carry the day... Read more
|
Finance
| Response Genetics Announces $4 Million Private Placement
The Los Angeles-based molecular diagnostics company entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share.... Read more |
New Product
| DermaGenoma of Irvine Launches Test to Predict Frequency of Genital Herpes Outbreaks
"Until now, physicians have been unable to give patients an answer to the most common question asked by recently infected Genital Herpes patients: Will I have frequent outbreaks?," says DermaGenoma CEO Andy Goren. "Using the HerpesDX genetic test, a doctor can finally assess a patient's risk for frequent outbreaks" .... Read more |
Collaborations
| Bristol-Myers, Allergan in $413M Pain Drug Deal
The drug -- AGN-209323 -- is said to be ready for mid-stage human trials as a treatment for neuropathic pain, or chronic pain usually accompanied by tissue injury. It is common in people with arthritis, cancer, and nerve damage. The drug can be given orally ... Read more Watson and Columbia Labs in Deal Worth $92.5M
The companies will collaborate on a late stage clinical trial of Crinone for the prevention of premature birth in women with a short cervix. Crinone is used as a treatment for infertility and for secondary amenorrhea, or the lack of a menstrual period .... Read more |
Performance
| STAAR Surgical Generates $19.8 Million in Fourth Quarter Revenue
The Monrovia, Calif.-based ophthalmic device manufacturer reports 9% increase in revenues from sales. This increase was fueled by STAAR's international sales which grew by 17.3% .... Read more |
Divestiture
| Watson Selling Stake in ScinoPharm for $94 Million
"Watson's relationship with ScinoPharm has been long and beneficial. However, as we refocused our global business and increased our own active pharmaceutical ingredient (API) development and manufacturing capabilities, this relationship has become less strategic for our long-term growth," said Paul Bisaro, President and Chief Executive Officer of Watson .... Read more |
Personnel
| Bioness Appoints New President & CEO
The Valencia, Calif-based medical device company announced that its Board of Directors named Thomas G. Fogarty as the company's new President and CEO, effective February 4th. Fogarty succeeds former President and CEO Yitzhak Zilberman, who has left the company .... Read more |
| Jobs Available | 
C3 Jian (Inglewood) Founded in 2005, C3 Jian, Inc ("C3") is a clinical-stage biotechnology company based in Los Angeles, California whose technologies were pioneered in the laboratories of Dr. Wenyuan Shi at UCLA. We are developing novel products to diagnose, treat and prevent human, animal and plant diseases. Lead compounds are focused on bacterial and fungal infections, especially those occurring on mucosal surfaces and in industrial biofilms. Company is seeking:
Baxter (Los Angeles & Westlake Village)Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Company is seeking: Grifols Biologicals (Los Angeles)At its Los Angeles facility, Grifols manufactures plasma derived biopharmaceutical products. Company is seeking: St Jude Medical (Sylmar)
St Jude Cardiac Management Division in Sylmar designs and manufactures pacemakers. Company is seeking: |
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|